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PURPOSE. Besides being actively metabolized, lactate may also function as a signaling molecule
by activation of the G-protein–coupled receptor 81 (GPR81). Thus, we aimed to characterize
the metabolic effects of GPR81 activation in Mu¨ller cells.
METHOD. Primary Mu¨ller cells from mice were treated with and without 10 mM L-lactate in the
presence or absence of 6 mM glucose. The effects of lactate receptor GPR81 activation were
evaluated by the addition of 5 mM 3,5-DHBA (3,5-dihydroxybenzoic acid), a GPR81 agonist.
Western blot analyses were used to determine protein expression of GPR81. Cell survival was
assessed through 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT)
viability assays. Lactate release was quantified by commercially available lactate kits. 13C-
labeling studies via mass spectroscopy and Seahorse analyses were performed to evaluate
metabolism of lactate and glucose, and mitochondrial function. Finally, Mu¨ller cell function
was evaluated by measuring glutamate uptake.
RESULTS. The lactate receptor, GPR81, was upregulated during glucose deprivation. Treatment
with a GPR81 agonist did not affect Mu¨ller cell survival. However, GPR81 activation
diminished lactate release allowing lactate to be metabolized intracellularly. Furthermore,
GPR81 activation increased metabolism of glucose and mitochondrial function. Finally,
maximal glutamate uptake decreased in response to GPR81 activation during glucose
deprivation.
CONCLUSIONS. The present study revealed dual properties of lactate via functioning as an active
metabolic energy substrate and a regulatory molecule by activation of the GPR81 receptor in
primary Mu¨ller cells. Thus, combinational therapy of lactate and GPR81 agonists may be of
future interest in maintaining Mu¨ller cell survival, ultimately leading to increased resistance
toward retinal neurodegeneration.
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Mu¨ller cells are the main retinal glial cell. Among multipleessential functions, Mu¨ller cells are key components in
buffering molecules in the extracellular compartments of the
inner retina1,2 and aid in neuroprotection by removing
excessive glutamate from the synapse between bipolar cells
and retinal ganglion cells (RGCs) to prevent excitotoxicity.3–5
To facilitate these functions, Mu¨ller cells rely heavily on a steady
energy production. Mu¨ller cell energy metabolism is therefore
essential in sustaining RGC survival, thereby reducing the risk
of inner retinal conditions, such as glaucoma and diabetic
retinopathy.2,4,5 Previous studies have suggested that Mu¨ller
cells are predominantly glycolytic6–8 but shift to mitochondrial
metabolism during excessive stress, such as sparse glucose
availability and accumulation of reactive oxygen species
(ROS).9–11 With this in mind, lactate should be crucial during
physiological conditions in the retina since retinal lactate is
produced at a higher rate than pyruvate as the end product of
glycolysis. Moreover, retinal tissue expresses high amounts of
various monocarboxylate transporters (MCTs), which facilitate
lactate uptake. Additionally, especially Mu¨ller cells are known
to have a substantial expression of MCT-1 and MCT-4.12
We recently revealed that lactate is taken up and metabo-
lized prior to glucose by the human Mu¨ller cell line MIO-M1,13
consequently enhancing overall function and survival of the
Mu¨ller cells. Similar protective effects of lactate have been seen
in the brain, wherein cultured brain slices were able to
maintain synaptic function by the use of lactate as the single
energy source, and lactate, not glucose, was needed for
neurons to recover from hypoxic conditions.14–16
Besides being an active metabolite, lactate has also been
shown to play a potential role in neuronal signaling by the
activation of G-protein–coupled receptor 81 (GPR81), also
known as hydroxycarboxylic acid receptor 1 (HCAR1).17,18
GPR81 activates the Gi-mediated pathway, by which adenylate
cyclase is inhibited, resulting in a decrease of the second
messenger cyclic AMP (cAMP), thereby altering numerous
intracellular mechanisms. In line with this, a study performed in
GPR81-silenced BxPC3 cells led to reduced mitochondrial
activity and survival in specific cancer cells.19
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The presence of lactate receptor GPR81 was recently
revealed in high abundance in the retina, especially in RGCs
and Mu¨ller cells.20 Thus, it is tempting to suggest that lactate-
mediated protection occurs through the activation of GPR81.
We recently showed that exposure to 10 mM L-lactate
facilitated MIO-M1 cell function and survival during sufficient
and insufficient glucose supply, mimicking the healthy and
diseased retina, respectively. Since the retinal condition
glaucoma is associated with periods of hypo- and hyperocular
perfusion21–23 it is likely that glucose is taken up during normal
perfusion and is metabolized to lactate during hypoperfusion.
Lactate may therefore serve as an energy substrate and
mediator of neuroprotection during fluctuating energy avail-
ability. We therefore aimed to investigate the metabolic
implications of treatment with 10 mM L-lactate in glucose-
supplemented and glucose-deprived primary Mu¨ller cells from
mice. Furthermore, treatment with 5 mM of a GPR81 agonist
(3,5-dihydroxybenzoic acid) was used to examine whether the
lactate-linked effects were due to direct metabolism of L-lactate
or through GPR81 activation.
METHODS
Cell Cultures
Primary Mu¨ller cells were cultured from dissected retinas of
neonatal mice (C57Bl/6JRj; Janvier, Le Genest-Saint-Isle,
France) at postnatal days 7 or 8. The mice were euthanized
by cervical dislocation and the eyes were taken out and
transferred to a tube with Dulbecco’s phosphate buffered
saline (D-PBS). Retinas were dissected under a microscope
(Leica S4E; Brønshøj, Denmark). The purification of Mu¨ller
cells was obtained according to the method previously
described.5,13 For some experiments Mu¨ller cells were purified
simultaneously with RGCs. In these purifications, cell suspen-
sion containing Mu¨ller cells, after respectively negative
selection for macrophages and positive selection for RGCs,
were seeded out directly in the wells/flasks.5 In other cases,
the dissected retinas were incubated for 30 minutes in
Dulbecco’s modified Eagle’s medium, DMEM (21885; Gibco,
Life Technologies, Thermo Fisher, Hvidovre, Denmark) supple-
mented with collagenase (65 U/mL) and trypsin (0.25%).
Afterward, the cells were rinsed thrice in DMEM containing
10% fetal bovine serum (Gibco, Life Technologies) to terminate
the digestion. The digested retinas were mechanically dissoci-
ated by gentle trituration through a 16- to 18-gauge needle,
producing a cell suspension of tissue microaggregates and
single cells. Cells were seeded in tissue culture plates and
flasks (TPP Switzerland, Trasadingen) at a density of 0.7 to 2
retina/cm2 depending on the particular plates and/or flasks (96
well, 24 well, 6 well, etc.). Cells were maintained at 378C in a
humidified atmosphere with 5% CO2 cultured in DMEM
containing glucose (1 g/L), pyruvate (1 mM), L-alanyl-glutamine
(3.97 mM), supplemented with penicillin (90 U/mL) and
streptomycin (90 lg/mL), and 10% fetal bovine serum (Gibco,
Life Technologies). The Mu¨ller cells were rinsed vigorously
three or four times 48 hours after seeding to prevent the
attachment of other cells to the plates. The cells were kept in
culture until confluency reached 80% to 90%. The culture
medium was changed twice a week. Aggregates and debris
were removed by forcible resuspension of medium onto the
cell monolayer. Cell cultures of approximately 80% to 90%
confluency were used for experiments. Cell culture medium
was changed 1 day prior to all experiments. Figure 1 shows a
representative image of the Mu¨ller cell cultures. Research
animals were cared for in accordance with the ARVO Statement
for the Use of Animals in Ophthalmic and Vision Research.
Western Blot Analysis
Primary mouse Mu¨ller cell cultures were scraped off after
treatment for 2 hours with or without 6 mM glucose (DMEM
A1443001; Gibco, Life Technologies). The cells were centri-
fuged at 8000g for 10 minutes at 48C. Supernatants were
discarded and cells were lysed in 30 lL radioimmune
precipitation assay (RIPA) buffer (Sigma-Aldrich, Søborg, Den-
mark), which also included protease cocktail inhibitors 1 and 2
(Sigma-Aldrich). Protein lysates were centrifuged at 8000g for
10 minutes at 48C. The samples containing 22 lg proteins were
loaded onto gels to investigate protein expression of GPR81 by
the use of a GPR81 antibody (cat. no. SAB1300090; Sigma-
Aldrich). The blots were preincubated for 1 hour with Tris-
buffered saline (TBS) (20 mM Tris-HCl, 150 mM NaCl)
containing 5% nonfat dry milk. Afterward, the blots were
incubated with a primary antibody against GPR81 (dilution
1:200) in TBS 1% nonfat dry milk overnight at 48C. The blots
were washed in TBS and incubated with the secondary
antibody, goat anti-rabbit IgG alkaline phosphatase–conjugated
secondary antibody (Jackson ImmunoResearch, West Grove,
PA, USA), followed by visualization using BCIP/NBT (5-bromo-
4-chloro-3-indoyl phosphate-nitro blue tetrazolium) substrate
(Kirkegaard & Perry Laboratories, Gaithersburg, MD, USA). To
ensure that equal amounts of protein were loaded in each lane,
the membranes were incubated with beta-actin antibody at
dilution 1:1000 (Cell Signaling Technologies, Danvers, MA,
USA). Bands were quantified by densitometry through the use
of Fiji, ImageJ software (National Institutes of Health, Bethesda,
MD, USA). The density of each band was normalized to its own
beta-actin band.
MTT Viability Assay
Mu¨ller cell survival was determined by the colorimetric
method, MTT (3-[4,5-dimethyl-2-thiazolyl]-2,5-diphenyl-2H-tet-
razolium bromide), measuring the ability of viable cells to
reduce MTT. During treatment, the primary mouse Mu¨ller cell
cultures were incubated in DMEM (A1443001; Gibco, Life
Technologies) with the presence or absence of glucose
FIGURE 1. Primary murine Mu¨ller cell cultures. Light microscopy of
the Mu¨ller cell cultures (A, C). The Mu¨ller cells positively expressed the
Mu¨ller cell–specific marker, glutamine synthetase (GS) (B). Addition-
ally, Mu¨ller cells expressed the glial cell–specific glutamate transporter
EAAT1 (D). All images were acquired through a 320/0.5 objective.
Scale bar: 100 lm.
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combined with the presence and absence of 10 mM L-lactate
and/or 5 mM of the GPR81 agonist, 3,5-dihydroxybenzoic acid
(3,5-DHBA) (Sigma-Aldrich) for 2 hours. Afterward, the cells
were incubated with 12 mM MTT solution for 1 hour at 378C
and the cells were solubilized in 10% sodium dodecyl sulfate
(SDS) and 0.01 M HCl. Eighteen hours later, the absorbance
was measured at 560 nm. The background readings (blank
wells with medium, MTT solution, and solubilizing buffer)
were subtracted from the absorbance readings of the treated
wells to obtain an adjusted absorbance reading representing
cell viability. Finally, the readings were divided by the adjusted
absorbance readings of control cells (6 mM glucose) to obtain a
percentage of cell survival.
Lactate Assay
Primary Mu¨ller cells were treated with DMEM (A1443001;
Gibco, Life Technologies) with or without the presence of 6
mM glucose for 2 hours at 378C. The media was transferred to a
10-KDa spin filter (Amicon Ultra4, UFC801024; Merck, Søborg,
Denmark) for 15 minutes at 4000g at 48C to remove lactate
dehydrogenase. The cells were afterward scraped off and
centrifuged at 20,000g at 48C for 20 minutes. The pellet was
reconstituted in 100 lL 1 M potassium hydroxide (KOH) and
protein content was measured by BCA protein assay (Sigma-
Aldrich). The lactate measurements of the media were
performed by using colorimetric detection through the Lactate
Assay Kit (MAK064-1KT; Sigma-Aldrich) according to the
manufacturer’s protocol. Absorbance was read at 560 nm.
Metabolic Labeling Studies
To examine lactate metabolism in the primary Mu¨ller cells, the
cells were incubated for 2 hours at 378C in basic DMEM
(A1443001; Gibco, Life Technologies) in the presence (6 mM)
or absence (0 mM) of unlabeled D-glucose. At the start of
incubation (Time ¼ 0 hours), the cells were spiked with an
aliquot of sodium L-[U-13C] lactate (98% [13C] enriched; CLM-
1579-PK; Cambridge Isotopes Laboratories, Inc., Tewksbury,
MA, USA) to a final concentration of 10 mM L-lactate. Other
conditions required incubation with 6 mM labeled D-glucose
(D-[13C] glucose (99%) [13C] enriched; CLM-1396-10; Cam-
bridge Isotopes Laboratories, Inc.) with and without spiking of
unlabeled sodium lactate to a final concentration of 10 mM or
spiking with a GPR81 agonist to a final concentration of 5 mM.
After the 2-hour incubation, the medium was collected and
cells were rinsed twice with ice-cold PBS. Subsequently, the
cells were extracted in 70% ethanol and centrifuged (20,000g
and 20 minutes at 48C) to separate the soluble extract
(supernatant) from insoluble components (pellet). Protein
content was determined in the pellets via the BCA protein
assay kit (Sigma-Aldrich) using BSA as standard. Media and cell
extracts were both lyophilized and reconstituted in water for
further biochemical analysis by gas chromatography coupled to
mass spectrometry (GC-MS). Spectrometric analyses were
performed as previously described.24 Briefly, extract and media
samples were adjusted to pH 1–2 with HCl and evaporated to
dryness under nitrogen flow. Analytes were extracted into an
organic phase (96% ethanol/benzene) followed by derivatiza-
tion with 14 % DMF/86% MTBSTFA with a modified procedure
from Mawhinney et al.25 Standards containing unlabeled
metabolites of interest and cell extracts were separated and
analyzed in a gas chromatograph (7820A chromatograph, J&W
GC column HP-5MS, parts no. 19091S-433; Agilent Technolo-
gies, Glostrup, Denmark) coupled to a mass spectrometer
(5977E; Agilent Technologies). The isotopic enrichment of the
metabolites of interest was corrected for natural abundance of
13C using the unlabeled standards and calculated according to
Biemann et al.26 Data are presented as labeling (%) of M þ X,
where M is the mass of the unlabeled molecule and X is the
number of labeled C-atoms in a given metabolite.
Bioenergetic Measurements Using the Seahorse
Analyzer
Mitochondrial respiratory function was measured using real-
time assessment of the oxygen consumption rate (OCR) with
the Seahorse XFe96 Extracellular Flux Analyzer (Agilent
Technologies). Primary mouse Mu¨ller cells were cultured in
a Seahorse 96-well cell culture microplate at a density
corresponding to 0.19 retina/well for 1 week. On the day of
the assay, cells were preincubated 2 hours before the analysis
under the different experimental conditions, namely, medium
with or without 6 mM glucose and/or 10 mM lactate in the
absence or presence of 5 mM 3,5-DHBA. Prior to the assay,
culture media were changed to unbuffered DMEM (pH 7.4)
supplemented with the different conditions and the cells
were equilibrated for 10 minutes at 378C in a CO2-free
incubator. Time of calibration inside the Seahorse instrument
was set for a further 15 minutes. Each OCR measurement
cycle consisted of 3-minute mix and 3-minute measurement
of the oxygen level. The analysis of mitochondrial function
was initiated by three baseline OCR measurement cycles.
These were followed by the sequential injection of oligomy-
cin, an ATP synthase (complex V) inhibitor (1 lM final
concentration), carbonyl cyanide-4 (trifluoromethoxy) phe-
nylhydrazone (FCCP, 2 lM), an uncoupling agent that
collapses the proton gradient, and a final injection of a
mixture of rotenone (1 lM), a complex I inhibitor, and
antimycin A (1 lM), a complex III inhibitor. The latter
combination shut down the mitochondrial respiration and
enabled the estimation of nonmitochondrial oxygen con-
sumption. Two OCR measurement cycles were taken in
between each injection and three final measurement cycles.
The pH of the reagents used to test mitochondrial function
was adjusted to 7.4. The OCR was recorded and calculated by
the Seahorse XFe96 software, Wave (Agilent Technologies). To
normalize the data after the Seahorse analysis, the protein
content for each well was measured using the Pierce BCA
assay with BSA as standard (Thermo Fisher Scientific,
Hvidovre, Denmark). Mitochondrial respiration parameters
were calculated from the OCR measurements as follows. Basal
respiration, nonmitochondrial respiration (minimum mea-
surement after rotenone/antimycin injection), was subtracted
from the last measurement obtained before oligomycin
injection; oxygen consumption associated with ATP produc-
tion, measurement after oligomycin injection, was subtracted
from the last measurement before oligomycin injection;
maximal respiration, measurement obtained after FCCP
injection; spare respiratory capacity, basal respiration sub-
tracted from maximal respiration. Results are expressed as
mean values 6 standard error of the mean (SEM) of three to
six different cell batches, at least 10 wells/condition in each
plate.
Glutamate Uptake Assay
The kinetic characterization of glutamate transport into the
primary mouse Mu¨ller cells was performed as described in
our previous studies.13 The primary mouse Mu¨ller cells were
cultured in 24-well plates with a density of 0.9 retina/mL and
cells were treated with the previously mentioned conditions
for 2 hours. The cells were preincubated for 3 minutes at 378C
in HBSS (HEPES buffered saline solution; 142 mM NaCl, 5 mM
KCl, 1 mM CaCl2, 1 mM MgCl2, 1 mM Na2 HPO4, and 10 mM
HEPES) containing different concentrations of L-glutamate
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(range, 2–50 lM). Subsequently, the cells were incubated for
an additional 3 minutes in HBSS including trace amounts (1:
200) of L-[3,4-3H]-glutamate (4 lCi/mL; Perkin-Elmer, Wal-
tham, MA, USA). The cellular content of radioactivity was
determined in cells extracted in KOH and analyzed by liquid
scintillation counting in a Liquid Scintillation Analyzer, Tri-
Carb 2900TR (Perkin-Elmer). Uptake rates were corrected for
protein concentrations, which were measured in the cell
extracts using BCA protein assay kit (Sigma-Aldrich). Unspe-
cific uptake was determined by incubation at 08C. Uptake
kinetics were assumed to follow the normal Michaelis–
Menten kinetics. The maximal uptake rate, Vmax, was
determined using a nonlinear regression in GraphPad Prism
7 (y ¼ Vmax  x/(Km þ x)).
Statistics
Data were analyzed using GraphPad software (GraphPad Prism
version 7.0, San Diego, CA, USA). Statistical comparisons
between two groups were analyzed by unpaired 2-tailed t-test.
Statistical comparisons between several groups were analyzed
by 1-way ANOVA followed by either Tukey’s multiple
comparison post test or Dunnett’s multiple comparison post
test to evaluate statistical differences between experimental
groups or compared to a common control, respectively.
Survival data, GC-MS data, and cellular bioenergetics were
analyzed using 2-way ANOVA (Tukey’s multiple comparisons
post hoc test). In all analyses P < 0.05 was considered to be
statistically significant.
RESULTS
GPR81 Protein Expression Increases During
Glucose Deprivation in Primary Mu¨ller Cells
To evaluate a potential regulation of lactate-mediated pathways
in response to glucose deprivation, we determined the protein
expression of the lactate receptor, GPR81. Protein expression
of GPR81 was upregulated 1.43 6 0.26 during glucose
deprivation for 2 hours (P < 0.05) (Fig. 2).
Primary Mu¨ller Cell Survival Is Unaffected by
GPR81 Activation, Whereas Lactate Exposure
Increases Survival During Glucose Deprivation
An MTT assay was used to investigate whether GPR81 was
toxic or compensatorily protective for the primary Mu¨ller cells.
Glucose deprivation for 2 hours was cytotoxic and
decreased primary Mu¨ller cell viability to 40.6 6 5.3% (P <
0.001). However, GPR81 did not affect survival, either in
glucose-deprived or glucose-supplemented cells. Exposure to
10 mM L-lactate increased survival of glucose-deprived cells by
33.4% (P < 0.05) (Fig. 3).
FIGURE 3. Unaffected primary Mu¨ller cell survival in response to GPR81 activation in the presence (A) and absence of glucose (B). Primary mouse
Mu¨ller cells were treated for 2 hours with (dotted columns) or without 5 mM of the GPR81 agonist, 3,5-DHBA, in the presence (black columns) and
absence of 6 mM glucose (gray columns). An MTT assay was used to quantify relative cell viability. Treatment with the GPR81 agonist did not have
any effect on cell viability, whereas the addition of 10 mM L-lactate during glucose deprivation increased cell viability. Values are presented as means
6 SEM of three to six experiments. *P < 0.05. Statistics: 1-way ANOVA (Tukey’s multiple comparisons test).
FIGURE 2. Increased GPR81 protein expression in primary Mu¨ller cells
in the absence of glucose. (A) A representative Western blot of GRP81
expression in primary mouse Mu¨ller cells treated for 2 hours in the
presence and absence of 6 mM glucose (GLC) (B) Relative expression
of GRP81 in conditions with 6 mM GLC (black column) and 0 mM GLC
(gray column). Values are presented as means 6 SEM of fold basal
change in three experiments. *P < 0.05. Statistics: unpaired t-test.
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Reduced Lactate Release in Primary Mu¨ller Cells in
Response to GPR81 Activation
Primary mouse Mu¨ller cells were treated for 2 hours with or
without 5 mM of the GPR81 agonist, 3,5-DHBA, in the
presence and absence of 6 mM glucose mimicking physiolog-
ical and subphysiological settings, respectively. Lactate was
released to the extracellular environment in all four conditions.
Within 2 hours, 8 6 1 mM lactate was released in the presence
of glucose, whereas only 1.2 6 0.2 mM was released during
glucose deprivation (P < 0.0001). Treatment with the GPR81
agonist decreased extracellularly released lactate amounts to 4
6 0.3 mM in the presence of glucose (P < 0.001). Extracellular
lactate amount remained low in the absence of glucose, and
GPR81 agonist treatment had no significant effect (Fig. 4).
Primary Mu¨ller Cells Prefer Lactate as a Metabolic
Substrate Prior to Glucose
To investigate whether primary Mu¨ller cells are able to utilize
lactate as energy substrate under glucose-supplemented and
glucose-deprived conditions, cultures of primary Mu¨ller cells
were incubated with [U-13C] lactate in absence or presence of
unlabeled glucose. GC-MS analyses were used to estimate the
percentile 13C-enrichment in lactate, alanine, and tricarboxylic
acid (TCA) cycle metabolites and amino acids obtained from
incubating the cells with [U-13C]-labeled substrates. After the
incubation with [U-13C] lactate, labeling was found in lactate
(Mþ3) (Fig. 5A), alanine, and metabolites produced after a first
turn (Mþ2) (Fig. 5B) and second turn (Mþ4) (Fig. 5C) of the
TCA cycle, demonstrating that lactate is readily taken up and
metabolized in the primary Mu¨ller cells (Fig. 5). The presence
of unlabeled glucose combined with labeled lactate increased
metabolism of the labeled lactate by yielding increased
intermediate TCA substrates, for example, alpha-ketoglutarate
(P < 0.01), glutamate (P < 0.01), malate (P < 0.01), and
aspartate (P < 0.01). To ensure a direct comparison among
metabolized labeled glucose versus metabolized labeled
lactate, an average value of the 13C-enrichment arising from
the metabolism of either 13C-glucose or 13C-lactate, molecular
carbon labeling (MCL), was calculated. The MCL of metabolites
was increased from 13C-lactate compared with 13C-glucose (P
< 0.05) (Fig. 6).
GPR81 Activation Boosts Metabolism of Glucose in
Primary Mu¨ller Cells
To further examine the substrate dependency, the metabolic
interplay between lactate and glucose, and the effect of GPR81
activation in the primary Mu¨ller cells, cells were incubated
with [U-13C] glucose in absence and presence of unlabeled
lactate or the GPR81 agonist, 3,5-DHBA. As expected, 13C
labeling was found in metabolites arising after the incubation
with [U-13C] glucose demonstrating the utilization of this
substrate as an energy source in primary Mu¨ller cells (Fig. 7).
However, a significant decrease in labeling was found in
virtually all measured metabolites when unlabeled lactate was
present. In the presence of the GPR81 agonist, the labeling
patterns in first-turn TCA cycle metabolites following [U-13C]
glucose metabolism were slightly increased while the 13C
FIGURE 4. Decreased lactate release in primary Mu¨ller cells in
response to GPR81 activation in the presence of glucose. Primary
mouse Mu¨ller cells were treated for 2 hours with (dotted columns) or
without 5 mM of the GPR81 agonist, 3,5-DHBA, in the presence (black
columns) and absence of 6 mM glucose (gray columns). A commercial
lactate assay kit was used to quantify the amounts of lactate released to
the media. Treatment with the GPR81 agonist resulted in reduced
amounts of released lactate. Values are presented as means 6 SEM of
four experiments. **P < 0.01, ***P < 0.001, ****P < 0.0001. Statistics: 1-
way ANOVA (Tukey’s multiple comparisons test).
FIGURE 5. Lactate is metabolized in primary Mu¨ller cells. Cultures were incubated for 2 hours at 378C in basic DMEM supplemented with 10 mM L-
[U-13C] lactate in absence (gray columns) or presence (gray column with black border) of unlabeled 6 mM glucose. At the end of the incubation,
cell extracts were collected and analyzed using GC-MS for determination of the percentage distribution of 13C-labeled metabolites presented by 13C-
labeling in Mþ3 for lactate and alanine (A) and in Mþ2 for metabolites obtained after a first run of the TCA cycle (B), as well as in the subsequent
turn of the TCA cycle, Mþ4 (C). The incorporation of 13C from [U-13C] lactate in amino acids and metabolites indicates that lactate is taken up and
used as substrate in primary Mu¨ller cells. No dilution of the labeling was obtained during combined labeled lactate and unlabeled glucose, indicating
that lactate is preferentially utilized as an energy substrate in these cells. Data are presented as labeling (%) of MþX, where M equals the mass of the
unlabeled molecule and X is the number of labeled C-atoms in a metabolite. Lac, lactate; ala, alanine; a-kg, alpha-ketoglutarate; asp, aspartate; glu,
glutamate; suc, succinate; mal, malate; fum, fumarate. Values are presented as means 6 SEM of four experiments. **P < 0.01. Statistics: 2-way
ANOVA (Tukey’s multiple comparisons test).
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labeling in second-turn metabolites was significantly upregu-
lated, suggesting an enhanced glucose metabolism induced by
activation of GPR81.
GPR81 Activation Increases Mitochondrial Activity
in Primary Mu¨ller Cells
Since GPR81 increased mitochondrial TCA cycle metabolite
synthesis, we aimed to further investigate the effect of GPR81
activation on mitochondrial respiratory function in primary
Mu¨ller cells. Oxygen consumption during mitochondrial
respiration was simultaneously monitored under different
conditions via the Seahorse XFe instrument and the OCR was
calculated in real time. Several compounds were employed to
assess mitochondrial respiration including oligomycin that
inhibits ATP synthase, FCCP that collapses the proton
gradient and induces a maximal consumption of oxygen and
a mixture of rotenone and antimycin A, complex I and
complex III inhibitors, respectively, that together shut down
mitochondrial respiration. Figures 8A and 8B show kinetic
traces of the changes in OCR throughout a typical mitochon-
drial function assay in primary Mu¨ller cells preincubated with
different substrates and conditions. From those traces, the
mitochondrial respiration parameters, including basal respi-
ration, ATP production associated with oxygen consumption,
maximal respiratory capacity, and spare respiratory capacity,
were calculated. The OCR values obtained in the presence of
lactate and/or glucose (Figs. 8C, 8D) were similar, indicating
that both glucose and lactate are efficient substrates for
mitochondrial respiration with lactate resulting in the highest
maximal respiratory capacity. In the presence of glucose,
mitochondrial respiration was increased after GP381 activa-
tion with 3,5-DHBA. Furthermore, the GPR81 agonist was
able to upregulate mitochondrial respiration in the absence of
glucose or lactate.
Glutamate Uptake in Primary Mouse Mu¨ller Cells
Decreases in Response to GPR81 Activation
Kinetic [3H]-glutamate uptake assays were performed on
primary Mu¨ller cells to investigate whether 10 mM L-lactate
exposure had a protective enhancing effect on the Mu¨ller cell
function, and whether the effects of L-lactate exposure and
GPR81 agonist exposure were the same in physiological and
pathophysiological settings: glucose-supplemented and glucose-
deprived cells, respectively. Maximal glutamate uptake in
primary Mu¨ller cells compensatorily increased from 0.84 6
0.23 nmol  min1  mg protein1 to 1.48 6 0.11 nmol  min1 
mg protein1 after 2 hours of glucose deprivation (P < 0.05)
(Fig. 9A). GPR81 agonist treatment for 2 hours had no significant
effect on glutamate uptake in glucose-supplemented cells (Fig.
9B). However, in glucose-deprived cells, GPR81 activation
resulted in a decreased maximal uptake of 0.83 6 0.27 nmol 
min1  mg protein1 after 2 hours (P < 0.05) (Fig. 9C). The
Michaelis–Menten constant of the glutamate uptake did not
change significantly in either of the mentioned conditions.
DISCUSSION
Lactate has often been overlooked as a metabolic reserve
molecule, but recent studies have put more emphasis on
FIGURE 6. Lactate is a preferential energy source in primary Mu¨ller
cells. Cultures were incubated for 2 hours at 378C in basic DMEM (0
mM glucose) and supplemented with either 10 mM L-[U-13C] lactate
(gray bars) or 6 mM D-[U-13C] glucose (black bars). At the end of the
incubation, cell extracts were collected and analyzed using GC-MS for
determination of the percentage distribution of 13C-labeled metabo-
lites. An average of the 13C-enrichment in selected metabolites arising
from metabolism of 13C-lactate or 13C-glucose is represented as the
molecular carbon labeling (MCL). The MCL is calculated by multiplying
the labeling (%) of the different isotopomers of a compound with the
number of labeled atoms in that particular isotopomer, summing these
products, and dividing them by the total number of carbon atoms in
the relevant compound. The MCL of several metabolites obtained from
13C-lactate was higher than the values calculated from 13C-glucose.
Values are presented as means 6 SEM of four experiments. *P < 0.05.
Statistics: 2-way ANOVA (Tukey’s multiple comparisons test).
FIGURE 7. Increased metabolism of 13C-glucose in primary Mu¨ller cells in response to GPR81 activation. Cultures were incubated for 2 hours at
378C in basic DMEM-supplemented 6 mM D-[U-13C] glucose in absence or presence of unlabeled 10 mM lactate, or the GPR81 agonist, 3,5-DHBA. At
the end of the incubation, cell extracts were collected and analyzed using GC-MS for determination of the percentage distribution of 13C-labeled
metabolites presented by 13C-labeling in Mþ3 for lactate and alanine (A) and in Mþ2 for metabolites obtained after a first run of the TCA cycle (B), as
well as in the subsequent turn of the TCA cycle, Mþ4 (C). The incorporation of 13C from [U-13C] glucose in amino acids and metabolites indicates
that glucose is taken up and used as substrate in primary Mu¨ller cells. However, lactate-induced decreased labeling in metabolites obtained from
[U-13C] glucose suggests that lactate is preferentially utilized as an energy substrate in these cells. The labeling in amino acids and metabolites
following [U-13C] glucose metabolism was increased in the presence of the GPR81 agonist, suggesting an enhanced glucose metabolism induced by
activation of GPR81. Data are presented as labeling (%) of MþX, where M equals the mass of the unlabeled molecule and X is the number of labeled
C-atoms in a metabolite. Lac, lactate; ala, alanine; a-kg, alpha-ketoglutarate; asp, aspartate; glu, glutamate; suc, succinate; mal, malate; fum, fumarate.
Values are presented as means 6 SEM of four experiments. *P < 0.05. Statistics: 2-way ANOVA (Tukey’s multiple comparisons test).
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characterizing lactate as more than a metabolic waste
product.27–30 Hence, another beneficial effect of lactate is its
possible neuroprotective property. In this context, lactate has
recently been shown to promote neuronal survival in models
of traumatic brain injury and ischemia.31,32 Moreover, lactate
has been linked to physiological restoration of long-term
memory.31–33 Similar advantageous properties of lactate have
been identified in the in the retina, where lactate treatment has
been shown to enhance Mu¨ller cell function and survival.13
Lactate has been demonstrated to exert its mechanism of
action by uptake through MCTs.12,13 However, in the early
2000s a new target for lactate was discovered, namely the
receptor GPR81. Abundant GPR81 expression was recently
identified the inner retina,20 indicating that activation of
GPR81 may play a prominent role in inner retinal homeostasis.
Thus, we aimed to elucidate whether the lactate-linked
protective effects on Mu¨ller cells were due to direct
metabolism of L-lactate and/or activation through GPR81.
Surprisingly, activation of GPR81 was shown to enhance
endogenous metabolic features of the Mu¨ller cells while
downregulating other functions, such as glutamate uptake,
depending on the energy status of the cell, shedding light on
the dual effects of lactate in Mu¨ller cells.
GPR81 protein expression has previously been verified in
isolated murine RGCs and Mu¨ller cells by immunostaining.
Moreover, mRNA expression levels of GPR81 have also been
quantified in retinas obtained from mice.20 However, in this
study, we aimed to verify the presence of the receptor and
possible regulations in response to altered levels of energy
availability. Deprivation of glucose led to increased GPR81
expression, indicating an amplification of lactate-mediated
effects through GPR81 activation. The presence of extracellu-
lar lactate has previously been shown to increase Mu¨ller cell
survival through uptake of lactate by MCT transporters,13 thus
indicating that lactate uptake is crucial for Mu¨ller cell viability.
Moreover, studies on various tumor cell lines have shown that
FIGURE 8. Mitochondrial function is enhanced by GPR81 activation. Cultures of primary Mu¨ller cells were incubated for 2 hours at 378C under the
indicated experimental conditions. (A, B) Oxygen consumption rate (OCR) was monitored using a Seahorse XFe96 Extracellular Flux Analyzer and a
standard mitochondrial function assay. OCR measurements were taken before (basal) and after the addition of the inhibitor of ATP synthase,
oligomycin (1 lM), the uncoupling agent FCCP (2 lM), and the inhibitors of mitochondrial complexes I and III, rotenone (Rot, 1 lM) and antimycin
A (Antim A, 1 lM), respectively. (C, D) Mitochondrial respiration parameters including basal mitochondrial respiration (basal), oxygen consumption
associated with ATP production (ATP production), maximal respiration (Maximal), and spare respiratory capacity (Spare) were calculated based on
the OCR measurements shown in (A, B), as described in Methods. The table summarizes the statistical comparisons of all relevant conditions. Values
are presented as means 6 SEM of six independent experiments (at least 10 wells/condition per Seahorse microplate). *P < 0.05, ***P < 0.001, ****P
< 0.0001, *****P < 0.00001. Statistics: 2-way ANOVA (Tukey’s multiple comparisons test).
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silencing GPR81 led to reduced survival,19 which could
support that lactate-mediated GPR81 activation is physiologi-
cally important in cell survival by activation of intracellular-
mediated pathways. Thus, previous studies suggest that lactate
uptake directly enhances cell survival, whereas lactate-mediat-
ed GPR81 activation may serve as a regulatory pathway that
maintains the intracellular lactate homeostasis. To elucidate the
role of GPR81 on primary mouse Mu¨ller cells, we investigated
whether GPR81 activation would counteract the protective
effects of lactate on cell survival. Surprisingly, the addition of 5
mM GPR81 agonist did not have any effect on survival, either
cytotoxic or cytoprotective effects. To further investigate the
link between GPR81 activation and lactate as a metabolite,
lactate release and metabolism was explored. During physio-
logical conditions, with sufficient amounts of glucose, lactate
was released in high amounts corresponding nicely to the
chosen lactate concentration of 10 mM in subsequent
experiments with extracellular lactate exposure. During
glucose deprivation, the extracellular concentration of lactate
diminished significantly, thereby suggesting that lactate was
metabolized internally instead of being released. Interestingly,
GPR81 activation also resulted in decreased lactate release in
the presence of glucose. In line with this, previous studies have
shown that lactate-mediated activation of GPR81 on adipocytes
inhibits lipolysis in vitro as well as in vivo,34–36 and 3,5-DHBA
has been verified as a specific agonist to facilitate this effect.36
It has been proposed that GPR81 activation of adipocytes is to
preserve energy as fat, especially during stress and short-term
starvation.37 During glucose deprivation in our study, we did
not establish any significant effect on lactate release in
response to GPR81 activation of the Mu¨ller cells. However, in
the presence of physiological glucose levels, lactate release
decreased significantly, thereby identifying that other metabol-
ic pathways, besides fat metabolism, are affected in response to
GPR81 activation. We furthermore elucidated the consequence
of GPR81 activation on glucose metabolism and identified an
increased glucose metabolism through oxidative phosphoryla-
tion in response to GRP81. Thus, GPR81 activation enhanced
glucose metabolism through the TCA cycle while bypassing
the production of lactate.
When exploring lactate metabolism, we found incorpora-
tion of 13C in metabolites after incubation with 13C-labeled
lactate, indicating that lactate is indeed metabolized in the
Mu¨ller cells. Interestingly, the addition of unlabeled glucose in
primary Mu¨ller cells increased metabolism of the labeled
lactate, revealing novel interactions of glucose and lactate in
Mu¨ller cells (Fig. 10). Thus, our findings suggest that the Mu¨ller
cells prefer lactate over glucose as an energy substrate. This
particular preference of energy substrates has also been seen in
the human Mu¨ller cell line MIO-M113 and is further supported
by the increase in MCL for selected metabolites from 13C-
lactate compared with 13C-glucose, emphasizing the role of
13C-lactate as a preferred energy substrate. Based on our
results, we hypothesize that Mu¨ller cells may compartmental-
ize their metabolism of glucose and lactate. Glucose may thus
be taken up and metabolized to lactate. In favor of this
hypothesis, we showed that lactate is subsequently released to
the extracellular environment. The increased amounts of
extracellular lactate may potentially result in a positive
feedback mechanism, followed by further increased lactate
uptake, since lactate was identified as a preferable energy
substrate (Fig. 10).
The combination of labeled glucose and 5 mM GPR81
agonist resulted in increased amounts of labeled metabolites,
FIGURE 9. Decreased maximal glutamate uptake in response to GPR81 activation in the absence of glucose. Primary mouse Mu¨ller cells were
treated for 2 hours with (dotted columns) or without 5 mM of the GPR81 agonist, 3,5-DHBA, in the presence (black columns) and absence of 6 mM
glucose (gray columns). Kinetic study of [3H]-glutamate uptake in the cells was performed. Nonlinear regression of the average uptake in the cells
at extracellular glutamate concentrations from 2 to 50 lM was estimated by GraphPad Prism with a calculated Michaelis–Menten constant, Km, and
a maximal uptake, Vmax, in glucose-supplemented cells compared to glucose-deprived cells (A) and glucose-supplemented cells (B) and glucose-
deprived cells (C) compared to treatment with either lactate or the GPR81 agonist, respectively. Treatment with the GPR81 agonist in the absence of
glucose resulted in reduced maximal glutamate uptake. Absence of glucose resulted in increased glutamate uptake compared to the condition with
glucose (Student’s t-test). Values are presented as means 6 SEM of three or four experiments. Vmax is presented in nmol  min1  mg protein. Km is
presented in lM. *P < 0.05. Statistics: 1-way ANOVA (Dunnett’s multiple comparisons test).
FIGURE 10. Glucose–lactate interaction hypothesis in Mu¨ller cells.
Glucose is taken up by the Mu¨ller cell and metabolized to lactate,
which is released to the extracellular environment. The increase in
extracellular lactate concentrations may potentially result in a positive
feedback mechanism, ultimately resulting in enhanced lactate uptake,
since lactate was identified as a preferable energy substrate.
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indicating that GPR81 activation boosts glucose metabolism.
This also correlates with the identified decrease in lactate
release during simultaneous glucose supplementation and
GPR81 activation as well as the increased mitochondrial
activity shown by Seahorse analysis.
In general, glucose deprivation has been shown to boost
mitochondrial activity in Mu¨ller cells, suggesting a shift from
glycolytic metabolism to mitochondrial oxidative phosphor-
ylation during metabolic stress.10,11 Since glucose deprivation
combined with GPR81 agonist treatment resulted in increased
mitochondrial function, it is tempting to suggest that GPR81
activation compensatorily increases metabolism of available
metabolites to meet the energy requirements. Moreover,
previous studies have identified that silencing of GPR81 in
cultured pancreatic carcinoma cells led to a 50% reduction in
mitochondrial activity within 24 hours,19 further emphasizing
that GPR81 is crucial in maintaining mitochondrial function.
To accommodate the need for increased resistance toward
the pathological stress defined by glucose deprivation, Mu¨ller
cells may thus upregulate GPR81 receptors to boost metabo-
lism and mitochondrial function. Once activated, a Gi-mediated
pathway will facilitate a decrease in cAMP.18 Interestingly, the
presence of cAMP has been shown to downregulate MCTs in
various cell types such as cerebrovascular endothelial cells and
intestinal epithelia.38,39 In this context, an increase in GPR81
receptor expression and activation would thus hypothetically
also result in an increased expression of MCTs followed by
enhanced lactate uptake and utilization. Ultimately, this may
explain why the cells do not need to take up glutamate as an
alternative energy source,9 since they have sufficient energy
substrates in the form of lactate. Correspondingly, we showed
a decrease in maximal glutamate uptake in response to GPR81
exposure. No significant changes in glutamate uptake was
found in cells treated with 10 mM lactate.
In the human MIO-M1 cell line, we have previously shown
that extracellular lactate availability increases the maximal
glutamate uptake after 2 hours glucose deprivation.13 These
contradictory findings may be explained by differences in the
energy status of the different cell types. Hence, MIO-M1 cells
were more prone to die during glucose deprivation compared
to primary Mu¨ller cells. Moreover, ATP production was
significantly reduced in MIO-M1 cells over time, whereas
primary Mu¨ller cells remained stable in their ATP production
and consumption. Thus, the differences may be explained by
their different thresholds for energetic crises. Consequently,
Mu¨ller cells in general may compensatorily increase their
glutamate uptake to meet the requirements for further energy
substrates; however, once having reached the threshold of
compensation, the cells require additional available energy
substrates. This explanation corresponds with previous find-
ings, which have suggested that glutamate uptake is indirectly
dependent on glycolysis and lactate formation.13,40,41 However,
the cells may subside to mitochondrial energy production
during accumulative stress to potentially sustain the gradient-
driven transport of glutamate by indirectly maintaining the
sodium–potassium pump.11
Nevertheless, the dual role of lactate as a metabolite and
signaling molecule by GPR81 activation has revealed novel
regulatory features of lactate, in which GPR81 activation is
able to boost mitochondrial metabolism and function,
ultimately leading to maintained survival of Mu¨ller cells. In
summary, the present study reveals novel properties of
lactate as an active metabolic energy substrate and as a
regulatory molecule that activates GPR81 receptors in
primary Mu¨ller cells. The dual properties of lactate and the
intricate details of lactate metabolism and signaling still
remain to be explored.
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